Castle Biosciences reports preliminary data from atopic dermatitis test study [Yahoo! Finance]
Castle Biosciences, Inc. - Common stock (CSTL)
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
The test aims to detect patients more likely to achieve a 'super response' to targeted therapies, marked by a 90% or greater decrease in disease severity as per the Eczema Area and Severity Index (EASI) score within three months. With over 1,100 subjects enrolled across 39 clinical study sites, the company is developing and validating this study. By detecting the immune pathways driving the disease, the test could lead to ‘effective' treatment strategies, reducing the current 'trial-and-error' method. The company anticipates launching the test by the end of next year. Castle Biosciences president and CEO Derek Maetzold said: “It is estimated that there are more than six million patients diagnosed with moderate-to-severe AD in the US seeking treatment annually, and approximately 760,000 of these patients seek systemic treatment. “Today, once a clinician and patient determine that systemic therapy is needed to control the patient's AD, a ‘trial-and-error' treatment cycle begins
Show less
Read more
Impact Snapshot
Event Time:
CSTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSTL alerts
High impacting Castle Biosciences, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CSTL
News
- MindMed Stock Skyrockets 94% Year to Date: What's Driving It? [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile Test [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile TestBusiness Wire
- Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- 4 Solid Net Profit Margin Stocks to Boost Portfolio Returns [Yahoo! Finance]Yahoo! Finance
CSTL
Earnings
- 11/4/24 - Beat
CSTL
Sec Filings
- 12/19/24 - Form 4
- 12/17/24 - Form 4
- 12/13/24 - Form 144
- CSTL's page on the SEC website